Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")
Clinical trial NCT04510987 · COMPLETED
Trial details
- NCT number
- NCT04510987
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2021-09-13
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.